Lung Cancer Trial, Recruiting NCT06717334 Sponsor: Memorial Sloan Kettering Cancer Center Condition: Lung Cancer
Back to Lung Cancer

Lung Cancer Trial, Recruiting

NCT06717334
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are between 50 and 80 years old
  • You have a smoking history of at least 20 pack-years (for example, smoking 1 pack per day for 20 years, or 2 packs per day for 10 years)
  • You have lost between 3% and 10% of your body weight at some point in the last 18 months, and this weight loss is not clearly explained by a known medical condition (the trial doctor will make this judgment; unintentional weight loss counts, but even some intentional weight loss may still qualify — confirm with trial site)
  • Your doctor believes you are expected to live for more than 1 year

Who may not be able to join:

  • You are currently pregnant or trying to become pregnant
  • You have had a CT scan of your chest (either a standard scan or a low-dose lung screening scan) within the past 12 months
  • You have a previous diagnosis of non-small cell lung cancer (note: a history of other types of cancer does not automatically disqualify you)
  • You are currently being evaluated or referred for investigation of a possible cancer — for example, you are scheduled for a biopsy or have been referred to a cancer specialist based on a suspicious scan result
  • You carry an inherited genetic variant linked to cancer risk AND have had a whole-body MRI scan within the past 12 months (confirm with trial site)
  • You are unable to follow the study procedures as required

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Puneeth Iyengar, MD, PhD, Memorial Sloan Kettering Cancer Center

Phone: 212-639-5159

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
2 December 2024
Est. completion
1 December 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

The incidence of lung cancer in patients with unexplained weight loss

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov